BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

myNEO

myNEO logo

Founded
2018
Geography
Belgium based

myNEO leads in Personalized Medicine and genomic-informed drug discovery in the key therapeutic areas of oncology and immunology.


Posts Mentioning This Company

R&D Platform

The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that predicts the most efficacious targets for each individual cancer patient, key to developing a successful personalized immunotherapy. In parallel, the DataScovery© platform continuously screens public and privately gathered databases to discover new immunogenic targets for both untackled cancer indications and new infectious diseases. To coninously increase clinical performance of the platform, data of all patients across biopharma partners are combined into one centralized myNEO network.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet